Global Women's Health Market is poised to grow at a CAGR of over 4.5% to reach $47 billion by 2026

The global women health market is driven by the rising prevalence of women-centric diseases, new products for women health, government initiatives to curb population growth, and growing demand for contraceptives to avoid unwanted pregnancies.
BRUSSELS - May 27, 2022 - PRLog -- Women's Health is a branch of medicine that focuses on the prevention and diagnosis of diseases that affect a woman's physical and emotional well-being. It encompasses a broad variety of treatments, drugs, and surgical products for diseases related to women.

Emerging Opportunities in the Women's Health Market

The rising prevalence of infectious and chronic diseases amongst a large group of the female population is a key factor driving the women's health market. Recent advances in genomics, tissue engineering, artificial intelligence, and cell and gene therapy have synergized a new wave of healthcare innovations that can be applied to create products and solutions specific to women's conditions.

For example, researchers are studying transcriptomics (the study of RNA molecules in a cell) for treating elusive conditions such as preeclampsia or preterm birth. Genomics is another research area that can help researchers in realizing the potential of personalized medicine. There has been extraordinary growth in terms of technology from predictive AI solutions to modeling unique DNA profiles. A favorable environment for research activities is expected to further drive growth opportunities in this market.

Key Challenges/ Constraints: Women's Health Market

The high cost associated with clinical care in some countries and side effects associated with the usage of few women health drugs (such as night sweats, headache, nausea, and difficulty sleeping) is likely to restrain the growth of the women's health market.

Regional Overview: Women's Health Market

North America has the largest women's health market, followed by Europe and APAC. The large share of North America can be attributed to the strong economies of the US and Canada, established reimbursement policies, early approval & commercialization of products, and the presence of key market players in this region. APAC holds a minor share in the global market.

Competitive Landscape Analysis: Global Women's Health Market

The key players operating in the women's health market are AbbVie Inc, Eli Lilly, Pfizer Inc., Merck & Co., Ferring Pharmaceuticals, LUPIN, Bayer AG, AstraZeneca, Novartis AG, Mithra Pharmaceuticals, Allergan, among others.

Get Customized Market Research Report on Women's Health Market @

Medi-Tech Insights
32 498868079
Email:*** Email Verified
Tags:Womens Health Market
Location:Brussels - Brussels - Belgium
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Medi-Tech Insights News
Most Viewed
Daily News

Like PRLog?
Click to Share